~38 spots leftby Dec 2025

Photodynamic Therapy vs Chemical Peels for Actinic Keratosis

Recruiting in Palo Alto (17 mi)
Murad Alam, MD | Northwestern Medicine
Overseen byMurad Alam, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Northwestern University
No Placebo Group
Prior Safety Data

Trial Summary

What is the purpose of this trial?

The purpose of this study is to to compare photodynamic therapy (PDT) versus the combination of Jessner's solution and 35% trichloroacetic acid (TCA) chemical peels for the treatment of actinic keratoses on upper extremities. This is a randomized clinical trial. Approximately 60 participants with actinic keratoses on both upper arms will be randomized to have one arm receive photodynamic therapy, while the contralateral arm receives Jessner's solution followed immediately by 35% TCA. AKs will be counted before treatment and 2-8 weeks after treatment. This study is a pilot study designed to determine the feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

Research Team

Murad Alam, MD | Northwestern Medicine

Murad Alam, MD

Principal Investigator

Northwestern University

Eligibility Criteria

This trial is for adults over 18 in the Chicago area who want to treat actinic keratoses on both upper arms and are in good health. They must understand and sign a consent form. Pregnant or nursing individuals, those with communication issues, or extensive skin conditions like eczema or psoriasis on their arms cannot participate.

Inclusion Criteria

I am older than 18 years.
I want treatment for skin lesions on both of my upper arms.
In good general health as assessed by the investigator
See 1 more

Exclusion Criteria

You have severe skin conditions on your arms that would make it hard for you to receive treatment.
Subject unwilling to sign an IRB approved consent form
I can communicate and cooperate with my doctor without issues.
See 1 more

Treatment Details

Interventions

  • Chemical Peels (Other)
  • Photodynamic Therapy (Other)
Trial OverviewThe study compares two treatments for actinic keratosis: photodynamic therapy (PDT) on one arm versus a chemical peel using Jessner's solution and trichloroacetic acid (TCA) on the other arm. Each participant receives both treatments, one on each arm, to see which works better.
Participant Groups
2Treatment groups
Active Control
Group I: Chemical PeelsActive Control1 Intervention
One upper arm will be exposed to Jessner's Solution AND 35% Trichloroacetic acid peel
Group II: Photodynamic TherapyActive Control1 Intervention
One upper arm will be exposed to blue light therapy

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+
Dr. Jeffrey Sherman profile image

Dr. Jeffrey Sherman

Northwestern University

Chief Medical Officer

MD from Northwestern University

Dr. Alicia Löffler profile image

Dr. Alicia Löffler

Northwestern University

Chief Executive Officer since 2010

PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech